Related Experiment Video
Updated: Jul 17, 2026

Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
Gut microbe-generated metabolite trimethylamine N-oxide and risk of abdominal aortic aneurysm: a cohort study
Xinmin S Li1,2, Meng Wang3, Zeneng Wang1,2
1Department of Heart, Blood, and Kidney Research, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Background And Aims:
Abdominal aortic aneurysms (AAAs) are associated with increased mortality in older adults. The gut microbe-generated metabolite trimethylamine N-oxide (TMAO) has been linked to AAA risk and promotes AAA progression in animal models. Whether circulating TMAO levels in apparently healthy older adults predict AAA development and adverse AAA outcomes remains unknown.
Methods:
Plasma TMAO levels were quantified using stable isotope dilution liquid chromatography-tandem mass spectrometry in 4442 community-dwelling adults (aged ≥65 years) in the Cardiovascular Health Study. Participants underwent ultrasound screening and prospective follow-up. Multivariable models assessed associations of serial TMAO levels with AAA development and incident risk for adverse AAA events, adjusting for traditional risk factors, renal function, socioeconomic status, and cardiometabolic lifestyle factors.
Results:
Higher baseline TMAO levels were associated with larger infrarenal aortic diameter and increased AAA risk. Over a median 12.2-year follow-up (54 402 person-years), 79 participants experienced incident adverse AAA events (repair, rupture, or AAA-related death). Elevated TMAO levels were independently associated with higher risk of adverse AAA events, whether modelled continuously [adjusted hazard ratio (HR) 1.28, 95% confidence interval (CI) 1.07-1.54 per doubling], by quantiles (HR for tertile 3 vs tertile 1: 2.46, 95% CI 1.32-4.59), or using a clinical threshold (≥6.2 µM; HR 1.93, 95% CI 1.25-2.99).
Conclusions:
In community-based older adults, higher TMAO levels were independently associated with increased risk of AAA development and adverse AAA events. Findings support TMAO as a novel risk factor for AAA and a potential therapeutic target for AAA prevention.
Insights
Higher levels of trimethylamine N-oxide (TMAO) in older adults are linked to increased risk of abdominal aortic aneurysm (AAA) development and adverse outcomes. This suggests TMAO is a potential target for AAA prevention.
Area of Science:
- Cardiovascular Science
- Metabolomics
- Gerontology
Background:
- Abdominal aortic aneurysms (AAAs) pose a significant mortality risk in older adults.
- Trimethylamine N-oxide (TMAO), a gut microbe metabolite, is implicated in AAA risk and progression.
- The predictive value of TMAO for AAA development in healthy older adults is unclear.
Purpose of the Study:
- To investigate the association between circulating TMAO levels and the incidence of AAA development.
- To determine if TMAO predicts adverse AAA outcomes in community-dwelling older adults.
Main Methods:
- Quantified plasma TMAO levels in 4442 adults aged ≥65 years using mass spectrometry.
- Utilized ultrasound screening and prospective follow-up for AAA assessment.
- Employed multivariable models to analyze TMAO associations with AAA development and adverse events, adjusting for confounders.
Main Results:
- Elevated TMAO levels correlated with larger aortic diameter and higher AAA risk.
- Over 12.2 years, higher TMAO independently predicted adverse AAA events (repair, rupture, death).
- Hazard ratios indicated a significant increased risk with higher TMAO levels.
Conclusions:
- Higher TMAO levels are independently associated with increased AAA risk and adverse events in older adults.
- TMAO emerges as a novel risk factor for abdominal aortic aneurysms.
- TMAO represents a potential therapeutic target for AAA prevention strategies.
Related Concept Videos
Microbiota Modulation by Antibiotics
Gut-Brain Axis
Dysbiosis of the Gut Microbiota
Microbiota of the Urogenital Tract